![Mark Bachleda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Bachleda
Director/Board Member at
LYELL IMMUNOPHARMA, INC.
Net worth: - $ as of 2026-06-29
Profile
Mark J.
Bachleda is currently Chief Executive Officer & Director at Eyconis, Inc. since 2024 and Independent Director at Lyell Immunopharma, Inc. starting in 2025.
Former positions include Vice President at Bristol Myers Squibb Co., Chief Commercial Officer at Galera Therapeutics, Inc. from 2021 to 2023, and Vice President-Sales & Account Management at Juno Therapeutics, Inc. Education includes an MBA from the University of California, Berkeley and a doctorate from the University of Illinois.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-09 | 0 ( -.--% ) | - $ | 2026-06-29 |
Mark Bachleda active positions
| Companies | Position | Start |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Director/Board Member | 2025-06-08 |
Former positions of Mark Bachleda
| Companies | Position | End |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-08-08 |
| JUNO THERAPEUTICS INC | Sales & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Mark Bachleda
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
- Stock Market
- Insiders
- Mark Bachleda
